Cargando…
Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
Sodium–glucose cotransporter-2 inhibitors (SGLT2is) are a relatively new class of antidiabetic drugs that have shown favorable effects in heart failure (HF) patients, irrespective of the left ventricular ejection fraction (LVEF). Recent studies have demonstrated the beneficial effects of empaglifloz...
Autores principales: | Xanthopoulos, Andrew, Katsiadas, Nikolaos, Skoularigkis, Spyridon, Magouliotis, Dimitrios E., Skopeliti, Niki, Patsilinakos, Sotirios, Briasoulis, Alexandros, Triposkiadis, Filippos, Skoularigis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455594/ https://www.ncbi.nlm.nih.gov/pubmed/37629635 http://dx.doi.org/10.3390/life13081778 |
Ejemplares similares
-
The effect of SGLT-2i administration on red blood cell distribution width in patients with heart failure and type 2 diabetes mellitus: A randomized study
por: Katsiadas, Nikolaos, et al.
Publicado: (2022) -
The Prognostic Role of Spot Urinary Sodium and Chloride in a Cohort of Hospitalized Advanced Heart Failure Patients: A Pilot Study
por: Xanthopoulos, Andrew, et al.
Publicado: (2023) -
Hypertensive Heart Failure
por: Triposkiadis, Filippos, et al.
Publicado: (2023) -
Patent hemostasis of radial artery: Comparison of two methods
por: Kyriakopoulos, Vassileios, et al.
Publicado: (2021) -
The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF
por: Triposkiadis, Filippos, et al.
Publicado: (2023)